Your browser does not support iframes.
N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Novartis AS Basel Namen AKT
(OP:
NVSEF
)
73.41
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
8:10 PM EDT, Jun 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Press releases about Novartis AS Basel Namen AKT
Novartis Completes Its Business Portfolio Restructuring, Divesting Gerber for US$5.5 Billion to Nestle
April 12, 2007
from
GlobeNewswire News Releases
Novartis Announces Initiative to Improve Access to State-of-the-Art Anti-Malarial Treatment Coartem
September 29, 2006
from
GlobeNewswire News Releases
New Drug Application for Rasilez, an Innovative Oral Renin Inhibitor to Treat High Blood Pressure, Accepted for U.S. Regulatory Review
July 27, 2006
from
GlobeNewswire News Releases
Novartis Delivers Strong Start to 2006 in First Quarter with Excellent Sales and Earnings Growth Performance
July 27, 2006
from
GlobeNewswire News Releases
Novartis Awarded Up to USD220 Million by U.S. Department of Health and Human Services for Development of Cell Culture-Derived Influenza Vaccine
May 04, 2006
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.